by dtrubin | Dec 4, 2019 | QoL, Rubin's Reflections
There is a growing number of people diagnosed with IBD who are defined as “elderly”. This varies in definition but can be considered those who have IBD older than 50 or older than 60 or 65. I prefer the World Health Organization definition of >65. The two different...
by dtrubin | Dec 3, 2019 | QoL, Rubin's Reflections
IBD, perhaps more than other chronic illnesses, can have a definite impact on a patient’s career choices and school performance. Therefore, I have definitely seen patients make decisions that are affected by their IBD. However, more often, I’ve seen patients overcome...
by dtrubin | Jun 13, 2019 | In the Press, Presentations, QoL
Philip Sossenheimer presented our work on wearable devices predicting disease activity in patients with IBD at Digestive Diseases Week 2019. Our study was featured in an article by Elizabeth Millard in Runner’s World titled, “Can Your Fitbit Tell You When a Common...
by dtrubin | Sep 21, 2017 | In the Press, QoL, therapies
Surgery an Alternative to Infliximab for Some People With Crohn’s Disease By Marilynn Larkin Dr. David Rubin, Chief of the Section of Gastroenterology, Hepatology, and Nutrition at the University of Chicago Medicine, agreed: “For some patients, as difficult as it may...
